Susquehanna International Group
PCVX icon

Susquehanna International Group’s Vaxcyte PCVX Stock Holding History

Susquehanna International Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3M Buy
435,400
+342,100
+367% +$18.6M ﹤0.01% 1927
2025
Q4 		$4.3M Buy
93,300
+6,100
+7% +$273K ﹤0.01% 4254
2025
Q3 		$3.14M Buy
87,200
+69,700
+398% +$2.31M ﹤0.01% 4893
2025
Q2 		$569K Buy
17,500
+300
+2% +$9.83K ﹤0.01% 8875
2025
Q1 		$649K Sell
17,200
-74,100
-81% -$5.92M ﹤0.01% 8326
2024
Q4 		$7.47M Sell
91,300
-104,200
-53% -$10.3M ﹤0.01% 3017
2024
Q3 		$22.3M Buy
195,500
+166,400
+572% +$15M ﹤0.01% 1720
2024
Q2 		$2.2M Sell
29,100
-15,700
-35% -$1.07M ﹤0.01% 4923
2024
Q1 		$3.06M Buy
44,800
+300
+0.7% +$20.8K ﹤0.01% 4479
2023
Q4 		$2.79M Buy
44,500
+35,600
+400% +$1.85M ﹤0.01% 4693
2023
Q3 		$454K Sell
8,900
-21,400
-71% -$1.06M ﹤0.01% 8462
2023
Q2 		$1.51M Buy
30,300
+6,400
+27% +$303K ﹤0.01% 5750
2023
Q1 		$896K Sell
23,900
-104,100
-81% -$4.42M ﹤0.01% 7101
2022
Q4 		$6.14M Buy
128,000
+104,400
+442% +$4.1M ﹤0.01% 2917
2022
Q3 		$566K Buy
+23,600
New +$598K ﹤0.01% 8162

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's PCVX Position: Q1 2026 in Review

Susquehanna International Group increased its Vaxcyte (PCVX) stake by 38% in Q1 2026, buying an estimated $703K and bringing the position to 47,073 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #5463.

Susquehanna International Group first reported a position in PCVX in Q2 2021 and has held it in 20 quarters since. The position peaked at $12M in Q1 2025. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Susquehanna International Group held 47,073 shares of Vaxcyte worth $2.74M as of Q1 2026.
  • Susquehanna International Group bought 12,957 Vaxcyte shares in Q1 2026, an estimated $703K.
  • Vaxcyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5463 holding.
  • Susquehanna International Group first reported a position in Vaxcyte in Q2 2021 and has held it in 20 quarters since.
  • Susquehanna International Group's Vaxcyte position peaked at $12M in Q1 2025.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.